[1]
“Role of Endothelin-1 Receptor Antagonist in Reducing Perioperative Pulmonary Arterial Hypertension after Surgical Correction of Ventricular Septal Defect”, Cardiovasc. j., vol. 9, no. 1, pp. 55–59, Sep. 2016, doi: 10.3329/cardio.v9i1.29544.